Furthermore, McCloud et al. reported anxiety regarding injections, new limitations to lifestyle, and uncertainty about treatment procedure being some of the concerns of patients with n-AMD undergoing anti-VEGF injections in at least one eye [34]. This evidence concerns the gene VEGFA and age-related macular degeneration.